Bemnifosbuvir is a synthetic nucleotide/nucleoside analogue, currently in clinical trials for hepatitis C, that has been identified as a highly effective inhibitor of the #hepatitis E virus (HEV).
#Virology #Pharmaceutical #MolecularBiology #sflorg
https://www.sflorg.com/2026/03/vi03202601.html